TORONTO–( BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed an international patent application that brings the potential to obtain patent coverage in 153 countries. The application, governed by the Patent Cooperation Treaty (“PCT”), grants the Company the right…


Previous articleVirtual Reality and Psychedelic Synergy
Next articleHealing Trip Tales: One Vet’s Ibogaine & 5-MeO-DMT Experience for PTSD and TBI